Fundraising FoxFOUNDATION MEDICAL PARTNERS — Full Portfolio
5 tracked investments · listed companies and verified rows first
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.
BiotechHealthtechMedical DevicesSan Mateo, US
Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in
BoardMichael Carusi(Director)inArda Minocherhomjee(Director)
Co-investorsAccelmed PartnersCanaan PartnersEvidity Health CapitalLightstone VenturesVCFA GroupDe Novo Ventures+1 more
HealthtechWaltham, US
Adam Gridley(Executive Officer, Director)Peter Greenleaf(Executive Officer, Director)
BoardJoshua Baltzell(Director)Kevin Rakin(Director)Garheng Kong, M.D., Ph.D.(Director)John J. Johnson(Director)
Co-investorsSofinnova VenturesSplit Rock Partners
BiotechRadnor, US
Scott Braunstein, MD(Executive Officer, Director)Edward F. Smith(Executive Officer)Joe Hulihan, MD(Executive Officer)
BoardNicole Vitullo(Director)Enrique J. Carrazana, MD(Director)Michael R. Dougherty(Director)
Co-investorsAvoro Capital AdvisorsBain Capital Life SciencesCanaan PartnersConnecticut InnovationsSofinnova VenturesDomain Associates+1 more
Burlington, US
Hari Sundram(Executive Officer)Christopher Coloian(Director)
BoardMichael Greeley(Director)inRobert Higgins(Director)Chip Hazard(Director)Patrick Flynn(Director)
Co-investorsNat TurnerFlybridge Capital PartnersGV (Google Ventures)Highland Capital Partners
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.